Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs

C. F. Verschraegen; B. E. Gilbert; A. J. Huaringa; R. Newman; N. Harris; F. J. Leyva; L. Keus; K. Campbell; T. Nelson-Taylor; V. Knight

doi:10.1111/j.1749-6632.2000.tb07063.x

Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs

C. F. Verschraegen
, B. E. Gilbert
, A. J. Huaringa
, R. Newman
, N. Harris
, F. J. Leyva
, L. Keus
, K. Campbell
, T. Nelson-Taylor
, V. Knight

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	352-354
Number of pages	3
Journal	Annals of the New York Academy of Sciences
Volume	922
DOIs	https://doi.org/10.1111/j.1749-6632.2000.tb07063.x
State	Published - 2000

Access to Document

10.1111/j.1749-6632.2000.tb07063.x

Cite this

Verschraegen, C. F., Gilbert, B. E., Huaringa, A. J., Newman, R., Harris, N., Leyva, F. J., Keus, L., Campbell, K., Nelson-Taylor, T., & Knight, V. (2000). Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs. Annals of the New York Academy of Sciences, 922, 352-354. https://doi.org/10.1111/j.1749-6632.2000.tb07063.x

@article{5fb77644fa0a4e17877896721cba5c69,

title = "Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs",

author = "Verschraegen, \{C. F.\} and Gilbert, \{B. E.\} and Huaringa, \{A. J.\} and R. Newman and N. Harris and Leyva, \{F. J.\} and L. Keus and K. Campbell and T. Nelson-Taylor and V. Knight",

year = "2000",

doi = "10.1111/j.1749-6632.2000.tb07063.x",

language = "English",

volume = "922",

pages = "352--354",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

}

Verschraegen, CF, Gilbert, BE, Huaringa, AJ, Newman, R, Harris, N, Leyva, FJ, Keus, L, Campbell, K, Nelson-Taylor, T & Knight, V 2000, 'Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs', Annals of the New York Academy of Sciences, vol. 922, pp. 352-354. https://doi.org/10.1111/j.1749-6632.2000.tb07063.x

TY - JOUR

T1 - Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs

AU - Verschraegen, C. F.

AU - Gilbert, B. E.

AU - Huaringa, A. J.

AU - Newman, R.

AU - Harris, N.

AU - Leyva, F. J.

AU - Keus, L.

AU - Campbell, K.

AU - Nelson-Taylor, T.

AU - Knight, V.

PY - 2000

Y1 - 2000

UR - https://www.scopus.com/pages/publications/0034514106

U2 - 10.1111/j.1749-6632.2000.tb07063.x

DO - 10.1111/j.1749-6632.2000.tb07063.x

M3 - Article

C2 - 11193921

AN - SCOPUS:0034514106

SN - 0077-8923

VL - 922

SP - 352

EP - 354

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -

Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs

Access to Document

Other files and links

Cite this